Welcome to our dedicated page for Markel Corporation SEC filings (Ticker: MKL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Markel Group Inc. filings document the financial reporting, governance, and capital-structure disclosures of a diversified holding company centered on specialty insurance. Its regulatory record includes 8-K reports for annual and quarterly results, Regulation FD materials such as shareholder letters, leadership and compensation changes, and reporting changes tied to business re-segmentation.
Proxy filings describe board matters, executive compensation, shareholder voting items, and equity-award disclosures. Other filings address registered securities and plan-interest matters, including Costa Farms LLC 401(k) Plan disclosures, while preserving Markel Group’s continuing reporting obligations for its common shares.
Markel Group Inc Schedule 13G: Vanguard Capital Management reports beneficial ownership of 654,077 shares of Common Stock, representing 5.20% of the class as of 03/31/2026. The filing states Vanguard Capital Management has sole dispositive power over 654,077 shares and sole voting power over 109,570 shares. The filing notes these holdings include shares held for Vanguard funds and managed accounts and that no single other person holds more than 5% of the class.
Markel Group Inc. reported a Q1 2026 net loss to shareholders of $212.3 million, compared with net income of $121.7 million a year earlier. Total operating revenues were stable at $3.55 billion, essentially unchanged from Q1 2025.
The main swing factor was net investment losses of $727.6 million, largely from lower equity valuations, versus losses of $149.1 million last year. Core insurance operations improved: the Markel Insurance combined ratio was 92.8%, better than 96.0% a year ago, helped by lower attritional losses and ongoing favorable prior-year reserve development.
Results included $35.0 million of losses from the Middle East conflict, partly offset by $106.9 million of favorable prior-year reserve development. Net investment income rose to $255.9 million, but operating cash flow dropped to $15.9 million from $376.2 million. Total assets were $68.6 billion and shareholders’ equity was $18.1 billion as of March 31, 2026.
Markel Group Inc. reported a Q1 2026 net loss to shareholders of $212.3 million, compared with net income of $121.7 million a year earlier. Total operating revenues were stable at $3.55 billion, essentially unchanged from Q1 2025.
The main swing factor was net investment losses of $727.6 million, largely from lower equity valuations, versus losses of $149.1 million last year. Core insurance operations improved: the Markel Insurance combined ratio was 92.8%, better than 96.0% a year ago, helped by lower attritional losses and ongoing favorable prior-year reserve development.
Results included $35.0 million of losses from the Middle East conflict, partly offset by $106.9 million of favorable prior-year reserve development. Net investment income rose to $255.9 million, but operating cash flow dropped to $15.9 million from $376.2 million. Total assets were $68.6 billion and shareholders’ equity was $18.1 billion as of March 31, 2026.
Markel Group Inc. reported a Q1 2026 net loss to shareholders of $212.3 million, compared with net income of $121.7 million a year earlier. Total operating revenues were stable at $3.55 billion, essentially unchanged from Q1 2025.
The main swing factor was net investment losses of $727.6 million, largely from lower equity valuations, versus losses of $149.1 million last year. Core insurance operations improved: the Markel Insurance combined ratio was 92.8%, better than 96.0% a year ago, helped by lower attritional losses and ongoing favorable prior-year reserve development.
Results included $35.0 million of losses from the Middle East conflict, partly offset by $106.9 million of favorable prior-year reserve development. Net investment income rose to $255.9 million, but operating cash flow dropped to $15.9 million from $376.2 million. Total assets were $68.6 billion and shareholders’ equity was $18.1 billion as of March 31, 2026.
MARKEL GROUP INC. executive Andrew G. Crowley reported small, routine equity acquisitions tied to employee benefit plans. On March 31, 2026, he acquired 9.2196 shares of common stock at $1,626.96 per share under the qualified component of the MKL 2020 Employee Stock Purchase Plan, in a transaction exempt under Exchange Act Rule 16b-3(c). Following this, he held 2,752.966 shares directly. Separately, his indirect holdings through the MKL 401(k) plan totaled 205.252 shares as of March 31, 2026, including 4.047 shares acquired in the plan between December 31, 2025 and March 31, 2026.
MARKEL GROUP INC. Chief Financial Officer Brian J. Costanzo reported routine share acquisitions tied to employee benefit plans. He acquired 1.8439 shares of common stock at $1,626.96 per share under the qualified component of the MKL 2020 Employee Stock Purchase Plan in a transaction exempt under Exchange Act Rule 16b-3(c). Between December 31, 2025 and March 31, 2026, he also acquired 2.487 shares through the MKL 401(k) plan, with a resulting indirect plan balance of 226.3230 shares as of March 31, 2026. Following these changes, he directly holds 1,613.0275 shares.
Markel Group Inc. is asking shareholders to vote at its May 20, 2026 annual meeting on electing 11 directors, approving executive pay on an advisory basis, and ratifying KPMG LLP as auditor. KPMG billed $11,314,787 in aggregate fees for 2025.
The Board also seeks approval of an amendment to the Articles of Incorporation that would, where Virginia law permits, replace certain default supermajority voting requirements with a majority-of-votes-entitled standard for major corporate actions, requiring more than two‑thirds of outstanding shares to pass. Shareholders will vote on two proposals: one requesting a report on environmental risk strategies and one to allow 10% holders to call special meetings; the Board recommends voting against both.
As of March 12, 2026, there were 12,547,039 common shares outstanding. The Vanguard Group and BlackRock, Inc. beneficially owned 9.50% and 6.08% of the stock, respectively.
Markel Group Inc Schedule 13G/A amendment reports that The Vanguard Group holds 0 shares of Common Stock, representing 0% of the class. The filing notes an internal realignment on 2026-01-12 under SEC Release No. 34-39538, after which certain Vanguard subsidiaries report holdings separately and The Vanguard Group is no longer deemed to beneficially own those securities. The amendment is signed by Ashley Grim on 03/27/2026.
The Board of Markel Group Inc. is soliciting proxies for the 2026 Annual Meeting of Shareholders to be held on May 20, 2026. Key items include election of eleven director nominees, an advisory vote on executive compensation, ratification of KPMG LLP as auditor, and a proposed amendment to the Articles of Incorporation. Shareholder proposals include a request for a report on environmental risk strategies and a proposal to lower the ownership threshold to call special meetings; the Board recommends voting FOR the Article amendment and AGAINST the shareholder proposals. The record date for voting is March 12, 2026. The proxy materials and the 2025 Annual Report are available online at the Company’s proxy materials site.
Costanzo Brian J. reported acquisition or exercise transactions in this Form 4 filing.
MARKEL GROUP INC. Chief Financial Officer Brian J. Costanzo reported an equity award of 654.641 shares of common stock in the form of restricted stock units granted at a price of $0.0000 per share on February 24, 2026.
According to the award terms, 539.739 RSUs are scheduled to vest on December 31, 2028, and 114.902 RSUs are scheduled to vest on February 24, 2029, subject to specified conditions. After this grant, he directly holds 1,611.1836 shares and indirectly holds 223.836 shares through a 401(k) plan based on the balance as of December 31, 2025.
MARKEL GROUP INC. executive Andrew G. Crowley, EVP & President of Markel Ventures, reported an equity award tied to 830.0200 shares of common stock on a grant, award, or other acquisition basis at a stated price of $0.0000 per share.
According to the footnotes, these are restricted stock units under the MKL 2024 Equity Incentive Compensation Plan, with 693.951 RSUs scheduled to vest on December 31, 2028, and 136.069 RSUs on February 24, 2029. After this grant, Crowley directly holds 2,743.7464 shares of common stock and indirectly holds 205.2520 shares through a MKL 401(k) plan, based on the plan balance as of December 31, 2025.